ct with contrast Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Karyopharm Therapeutics Inc (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadfolfiri regimen

I am/have/hadnon-small cell lung cancer

I am/have/hadcolorectal cancer

I am/have/hadsmall cell lung cancer

I am/have/hadlung cancer

I am/have/hadmetastatic nsclc

I am/have/hadstage iv non-small cell lung cancer

I am/have/haddrug test

I am/have/hadkras

I am/have/hadadjuvant therapy

I am/have/hadserum pregnancy test

I am/have/hadcancer therapy

I am/have/hadmonoclonal antibody therapy

I am/have/hadmeasurable disease

I am/have/hadmoderate hepatic impairment

I am/have/hadgilbert's syndrome

I am/have/hadcombination therapy

I am/have/hadmetastatic solid tumor

I am/have/hadcancer

I am/have/hadliver function tests

added new label for I am/have/had

more

I am looking for

I am looking forpembrolizumab

I am looking forprogrammed cell death protein 1

I am looking forfluorouracil

I am looking foririnotecan

I am looking fordocetaxel

I am looking forleucovorin

I am looking forkras

I am looking formonoclonal protein

I am looking forselinexor

I am looking foradjuvant

I am looking formonoclonal antibodies

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Bioequivalence and the Tolerability and Antitumor Activity of Selinexor Combination Treatment

This is a Phase 1, two-part, two-arm, open-label study in patients with NSCLC who have had 1 or 2 prior lines of treatment, with 1 line containing a CPI, or patients with CRC who have had 2 prior lines of treatment (oxaliplatin- and irinotecan-based) and no prior immunotherapy. The study …

folfiri regimen

non-small cell lung cancer

small cell lung cancer

leucovorin

kras

0 views
16 Feb, 2024
3 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.